Biosyent (TSXV:RX) Short Interest


TSXV:RX Biosyent Inc TSXV:RX
100 GF Score
Price C$14.05
GF Value C$16.11
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Biosyent Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

TSXV:RX vs ZTS: Short Interest Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Biosyent's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Biosyent Short Interest vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Biosyent's Short Interest distribution charts can be found below:

* The bar in red indicates where Biosyent's Short Interest falls into.


TSXV:RX
100GF Score
Biosyent Inc TSXV:RX
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Biosyent (TSXV:RX) Overvalued in 2026?

Based on GuruFocus' analysis, Biosyent stock appears to be undervalued. The current stock price of C$14.05 is trading 12.8% below its estimated GF Value™ of C$16.11. GuruFocus considers Biosyent to be Modestly Undervalued.

Key valuation signals for TSXV:RX:

  • Short Interest:
  • GF Value™: C$16.11 vs. price of C$14.05 (12.8% below fair value)
  • GF Score™: 100/100 with 2 warning signs

No single metric tells the full story. See the TSXV:RX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Biosyent Business Description

Other Exchanges BIOYF:USA
Address 2476 Argentia Road, Suite 402, Mississauga, ON, CAN, L5N 6M1
Biosyent Inc is a Canada-based growth-oriented specialty pharmaceutical company. It markets and delivers a diverse range of healthcare products, including over-the-counter, behind-the-counter, and prescription options. It has focused on in-licensing or acquiring originative pharmaceuticals and other healthcare products. Its product includes FeraMAX Pd, Inofolic, Gelclair, Cathejell, RepaGyn, Proktis-M, and Tibella. The company derives revenue from pharmaceutical and insecticide business. Geographically, it derives maximum revenue from Canada and also has its presence internationally.
100GF Score

Get the complete analysis for TSXV:RX

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

C$14.05
Price
C$16.11
GF Value